Cadila Healthcare Ltd. has received an order to supply one crore doses of its three-dose intradermal plasmid DNA vaccine to the Government of India. This makes it the fourth vaccine to be approved for use in India after Serum Institute’s Covishield, Bharat Biotech’s Covaxin and the Russian Covid-19 vaccine-Sputnik.
ZyCov-D, the world’s first plasmid DNA vaccine which comes with a needle-free applicator has been priced at Rs 265 per dose while the applicator would be offered at Rs 93 per dose. This price is excluding GST. The vaccine has a primary established efficacy of 66.66% for the symptomatic RT-PCR positive cases and the jab has been found safe for children in the age group of 12-18 years.
